90 related articles for article (PubMed ID: 29135049)
1. Functional characterization of E2F3b in human HepG2 liver cancer cell line.
Lu Y; Li W
J Cell Biochem; 2018 Apr; 119(4):3429-3439. PubMed ID: 29135049
[TBL] [Abstract][Full Text] [Related]
2. Characterization of E2F3a function in HepG2 liver cancer cells.
Li W; Ni GX; Zhang P; Zhang ZX; Li W; Wu Q
J Cell Biochem; 2010 Dec; 111(5):1244-51. PubMed ID: 20803551
[TBL] [Abstract][Full Text] [Related]
3. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
[TBL] [Abstract][Full Text] [Related]
4. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development.
Chong JL; Tsai SY; Sharma N; Opavsky R; Price R; Wu L; Fernandez SA; Leone G
Mol Cell Biol; 2009 Jan; 29(2):414-24. PubMed ID: 19015245
[TBL] [Abstract][Full Text] [Related]
5. E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation.
Asp P; Acosta-Alvear D; Tsikitis M; van Oevelen C; Dynlacht BD
Genes Dev; 2009 Jan; 23(1):37-53. PubMed ID: 19136625
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
[TBL] [Abstract][Full Text] [Related]
7. E2F3b over-expression in ovarian carcinomas and in BRCA1 haploinsufficient fallopian tube epithelium.
Smith NL; Welcsh P; Press JZ; Agnew KJ; Garcia R; Swisher EM
Genes Chromosomes Cancer; 2012 Nov; 51(11):1054-62. PubMed ID: 22887716
[TBL] [Abstract][Full Text] [Related]
8. Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma.
Kent LN; Bae S; Tsai SY; Tang X; Srivastava A; Koivisto C; Martin CK; Ridolfi E; Miller GC; Zorko SM; Plevris E; Hadjiyannis Y; Perez M; Nolan E; Kladney R; Westendorp B; de Bruin A; Fernandez S; Rosol TJ; Pohar KS; Pipas JM; Leone G
J Clin Invest; 2017 Mar; 127(3):830-842. PubMed ID: 28134624
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-17-92 Regulates the Transcription Factor E2F3b during Myogenesis In Vitro and In Vivo.
Tang Z; Liu N; Luo L; Kang K; Li L; Ni R; Qiu H; Gou D
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362317
[TBL] [Abstract][Full Text] [Related]
10. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
11. Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells.
Noguchi S; Mori T; Otsuka Y; Yamada N; Yasui Y; Iwasaki J; Kumazaki M; Maruo K; Akao Y
J Biol Chem; 2012 Apr; 287(15):11769-77. PubMed ID: 22354972
[TBL] [Abstract][Full Text] [Related]
12. E2f3 in tumor macrophages promotes lung metastasis.
Trikha P; Sharma N; Pena C; Reyes A; Pécot T; Khurshid S; Rawahneh M; Moffitt J; Stephens JA; Fernandez SA; Ostrowski MC; Leone G
Oncogene; 2016 Jul; 35(28):3636-46. PubMed ID: 26549026
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma.
Zeng X; Yin F; Liu X; Xu J; Xu Y; Huang J; Nan Y; Qiu X
Oncol Rep; 2014 Mar; 31(3):1139-46. PubMed ID: 24402082
[TBL] [Abstract][Full Text] [Related]
14. Transcription Factor E2F3a in Nucleus Accumbens Affects Cocaine Action via Transcription and Alternative Splicing.
Cates HM; Heller EA; Lardner CK; Purushothaman I; Peña CJ; Walker DM; Cahill ME; Neve RL; Shen L; Bagot RC; Nestler EJ
Biol Psychiatry; 2018 Aug; 84(3):167-179. PubMed ID: 29397901
[TBL] [Abstract][Full Text] [Related]
15. Opposing regulation of Sox2 by cell-cycle effectors E2f3a and E2f3b in neural stem cells.
Julian LM; Vandenbosch R; Pakenham CA; Andrusiak MG; Nguyen AP; McClellan KA; Svoboda DS; Lagace DC; Park DS; Leone G; Blais A; Slack RS
Cell Stem Cell; 2013 Apr; 12(4):440-52. PubMed ID: 23499385
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells.
Shan J; Lopez MC; Baker HV; Kilberg MS
Physiol Genomics; 2010 May; 41(3):315-27. PubMed ID: 20215415
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-199a-5p inhibits VEGF-induced tumorigenesis through targeting oxidored-nitro domain-containing protein 1 in human HepG2 cells.
Gui R; Huang R; Zhang JH; Wen XH; Nie XM
Oncol Rep; 2016 Apr; 35(4):2216-22. PubMed ID: 26781989
[TBL] [Abstract][Full Text] [Related]
18. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
19. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
20. Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2.
Luo Y; Wen X; Wang L; Gao J; Wang Z; Zhang C; Zhang P; Lu C; Duan L; Tian Y
Oxid Med Cell Longev; 2016; 2016():7530853. PubMed ID: 27597883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
